Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population.
Chin Med J (Engl)
; 134(1): 117-119, 2020 Oct 26.
Article
in En
| MEDLINE
| ID: mdl-33109951
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Antibodies, Monoclonal, Humanized
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Chin Med J (Engl)
Year:
2020
Document type:
Article
Affiliation country:
China